Health Science Policy Council Chair 2021 - 2023
Newell McElwee, PharmD, MSPH
Pharmaceutical professional, Boehringer Ingleheim
Gwynedd Valley, PA, United States
Past Chair 2019 - 2021
Shelby Reed, RPh, PhD
Professor, Duke Clinical Research Institute
Durham, NC, United States
Chair-Elect 2023 - 2025
Maarten IJzerman, MSc, PhD
Dean, Professor Cancer Health Services Research, University of Melbourne and University of Twente
Melbourne, VIC, Australia
Health Science Policy Council Members
Policy Outlook Committee
Co-Chairs
Lou Garrison, PhD
Professor Emeritus, The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute,
Seattle, WA, United States
Adrian Towse, Mphil, MA
Emeritus Director, Office of Health Economics
London, United Kingdom
Members
Suliman Alghnam, MHA
Head, Population Health, KAIMRC
Riyadh, 01, Saudi Arabia
Eric Barrette
Senior Director, Health Economics, Medtronic
Washington, DC, United States
Amanda Cole, PhD, BSc
Senior Principal Economist, Office of Health Economics
London, LON, United Kingdom
Sita Ratna Devi Duddi
CEO, Dakshayani and Amaravati Health and Education
Gurugram, HR, India
Eduardo Gonzalez-Pier, PhD
Distinguished Fellow, Center for Global Development
Cuidad de Mexico, Mexico
Jens Grueger, PhD
Director and Partner, Boston Consulting Group
Freiburg, BW, Germany
Jan E. Hansen, PhD, DrPH
Vice President, Evidence for Access, Genentech
South San Francisco, CA, United States
Finn Børlum Kristensen, PhD, MD
Danish Centre for Health Economics - University of Southern Denmark
Hilleroed, 84, Denmark
Newell McElwee, PharmD, MSPH
Pharmaceutical professional, Boehringer Ingleheim
Gwynedd Valley, PA, United States
Brian O'Rourke, PharmD
President, Brian O'Rourke Health Care Consulting Inc.
Ottawa, ON, Canada
Teodoro Padilla, MBA, BS
Executive Director, PHAP
Makati City, Philippines
Soualmi Redouane, MSc, PharmD
Head of Market Access & Government Affairs, Boehringer Ingelheim
Ouled Fayet, 16, Algeria
Martin Visnansky, MSc, MBA, PharmD, PhD
Senior Consultant / Lecturer, University of Veterinary Medicine and Human Pharmacy
Bratislava, Slovakia
Science/Research Committee
Co-Chairs
J. Jaime Caro, MD
Chief Scientist, Evidera
Bethesda, MD, United States
William Crown, PhD, BA, MA
Distinguished Research scientist, Brandeis University
Waltham, MA, United States
Members
Abdalla Abotaleb, MBA, PharmD, PhD, MD
World health organization (WHO)
cairo, C, Egypt
Paolo Cortesi, PhD
Assistant Professor, Research Centre on Public Health (CESP), University of Milan-Bicocca
Monza, MB, Italy
Jhony De La Cruz Vargas, MS, PhD, DrPH, MD
PRESIDENT ISPOR PERU, Universidad Ricardo Palma
Lima, LIM, Peru
Michael Drummond, PhD
Professor of Health Economics, University of York
York, YOR, United Kingdom
Stephanie Earnshaw, PhD
Senior Vice President, Health Economics, RTI Health Solutions
Pittsboro, NC, United States
Maarten IJzerman, MSc, PhD
Dean, Professor Cancer Health Services Research, University of Melbourne and University of Twente
Melbourne, VIC, Australia
Khalid Kamal, MS, PhD
Professor and Chair, West Virginia University
Morgantown, WV, United States
Natia Kvizhinadze, PharmD
Professor, Social & Clinical Pharmacy, Tbilisi State Medical University
Tbilisi, Georgia
Vivian Lee, PharmD, BSc
Associate Professor, The Chinese University of Hong Kong
Shatin, Hong Kong
Josephine Mauskopf, PhD
Vice President, Health Economics, RTI Health Solutions
Research Triangle Park, NC, United States
Shelby Reed, RPh, PhD
Professor, Duke Clinical Research Institute
Durham, NC, United States
Tienie Stander
VI Research
Dubai, United Arab Emirates
Ben van Hout, MSc, PhD
Scientific Director, Pharmerit International
York, United Kingdom
Hwee-Lin Wee, PhD
Associate Professor, National University of Singapore
Singapore, Singapore
Task Force Review Committee
Co-Chairs
Deborah Marshall, PhD, BSc
Professor, Arthur J.E. Child Chair, University of Calgary
Calgary, AB, Canada
Mark Sculpher, MSc, PhD, BA
Professor, University of York
York, NYK, United Kingdom
Members
Federico Augustovski, MSc, PhD, MD
Director, HTA, (IECS) Institute for Clinical Effectiveness and Health Policy
Buenos Aires, B, Argentina
Marc Berger, MD
Marc L. Berger, LLC
New York, NY, United States
Joseph Cappelleri, MS, PhD, MPH
Executive Director, Pfizer Inc
Newington, CT, United States
Reed Johnson, PhD
Professor, Duke School of Medicine, Duke Clinical Research Institute
Durham, NC, United States
Daniel Malone, MS, RPh, PhD
Professor, University of Utah
Salt Lake City, UT, United States
C. Daniel Mullins, PhD
Professor, University of Maryland Baltimore
Baltimore, MD, United States
Scott Ramsey, PhD, MD
Full Member & Co-Director, Fred Hutchinson Cancer Research Center
Seattle, WA, United States
Mark S. Roberts, MD, MPP
Professor and Chair, Health Policy and Management, University of Pittsburgh
Pittsburgh, PA, United States
Julia F. Slejko, PhD
Associate Professor, University of Maryland School of Pharmacy
Baltimore, MD, United States
Praveen Thokala, PhD, MASc
Senior Research Fellow, ScHARR, The University of Sheffield
Sheffield, United Kingdom